BRAIN Biotech AG Statistics

Total Valuation

FRA:BNN has a market cap or net worth of EUR 41.07 million. The enterprise value is 31.97 million.

Market Cap	41.07M
Enterprise Value	31.97M

Important Dates

The next estimated earnings date is Thursday, August 28, 2025.

Earnings Date	Aug 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	21.85M
Shares Outstanding	n/a
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	8.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	5.71
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.34
EV / Sales	0.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-4.79

Financial Position

The company has a current ratio of 1.85, with a Debt / Equity ratio of 0.64.

Current Ratio	1.85
Quick Ratio	1.22
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	-0.69
Interest Coverage	-2.70

Financial Efficiency

Return on equity (ROE) is -102.10% and return on invested capital (ROIC) is -32.59%.

Return on Equity (ROE)	-102.10%
Return on Assets (ROA)	-8.42%
Return on Invested Capital (ROIC)	-32.59%
Return on Capital Employed (ROCE)	-17.05%
Revenue Per Employee	187,779
Profits Per Employee	-47,923
Employee Count	318
Asset Turnover	0.70
Inventory Turnover	2.55

Taxes

Income Tax	-236,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -23.88% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-23.88%
50-Day Moving Average	2.11
200-Day Moving Average	2.62
Relative Strength Index (RSI)	31.27
Average Volume (20 Days)	3,527

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:BNN had revenue of EUR 53.52 million and -13.66 million in losses. Loss per share was -0.63.

Revenue	53.52M
Gross Profit	29.12M
Operating Income	-10.26M
Pretax Income	-13.92M
Net Income	-13.66M
EBITDA	-6.87M
EBIT	-10.26M
Loss Per Share	-0.63

Full Income Statement

Balance Sheet

The company has 14.87 million in cash and 4.59 million in debt, giving a net cash position of 10.28 million.

Cash & Cash Equivalents	14.87M
Total Debt	4.59M
Net Cash	10.28M
Net Cash Per Share	n/a
Equity (Book Value)	7.19M
Book Value Per Share	0.28
Working Capital	16.01M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -5.35 million and capital expenditures -1.33 million, giving a free cash flow of -6.68 million.

Operating Cash Flow	-5.35M
Capital Expenditures	-1.33M
Free Cash Flow	-6.68M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 54.42%, with operating and profit margins of -19.18% and -25.52%.

Gross Margin	54.42%
Operating Margin	-19.18%
Pretax Margin	-26.00%
Profit Margin	-25.52%
EBITDA Margin	-12.83%
EBIT Margin	-19.18%
FCF Margin	n/a

Dividends & Yields

FRA:BNN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-33.25%
FCF Yield	-16.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:BNN has an Altman Z-Score of -1.02 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.02
Piotroski F-Score	1